Drugs / heptavalent pneumococcal conjugate vaccine
last change Jun 2006 re-read 2 minutes ago

heptavalent pneumococcal conjugate vaccine

Vaccine

Developed for
respiratory tract infectious disorder
Investigated by
Netherlands Organisation for Scientific Research · UMC Utrecht

Trials 1 · a red edge is where a trial was stopped

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00161122 Sep 2003 → Jun 2006 respiratory tract infectious disorder UMC Utrecht Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as heptavalent pneumococcal conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00161122
Modality Vaccine “combined heptavalent pneumococcal conjugate vaccine and trivalent inactivated influenza vaccine” NCT00161122